India, Aug. 6 -- Insmed Incorporated (INSM) shares surged $32.83, or 33.16 percent, to $131.85 on Thursday, after the biopharmaceutical company reported a sharply narrower second-quarter loss, strong product revenue growth, and raised its full-year outlook for Brinsupri.
The stock opened at $128.22 and traded between $126.48 and $137.70 during the session on the Nasdaq. It has traded in a 52-week range of $90.39 to $212.75. Trading volume reached 5.66 million shares, compared with an average daily volume of 4.02 million shares.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Second-quarter net loss narrowed to $13.24 million, or $0.06 per share, from $321.69 million, or $1.70 per share, a year earlier...